论文部分内容阅读
目的评价南京市地区肠内营养药物利用情况,为临床营养治疗合理使用和管理提供参考。方法对南京地区2008年至2010年肠内营养药物的零售金额、用药频度(DDDs)等指标进行统计分析与评价。结果南京地区肠内营养药物用量及用药总金额呈上升趋势,近两年年增长率大于34.80%,3年用药总金额排位前5位依次为能全力、百普力、瑞代、维沃、瑞能,大部分药物在3年间的销售增长率各有波动;DDDs 3年排位不变,前3名是能全力、百普力、瑞代。结论肠内营养药物使用增长幅度较大,但在营养药物使用中的比例却下降。如果患者肠道还保留有一定的功能,就应尽可能应用肠内营养药物。
Objective To evaluate the utilization of enteral nutrition in Nanjing and to provide reference for the rational use and management of clinical nutrition therapy. Methods The statistical analysis and evaluation were made on the retail sales of enteral nutrition drugs and DDDs in Nanjing from 2008 to 2010. Results The total amount of enteral nutrition and the total amount of medication in Nanjing showed an upward trend, with an annual growth rate of more than 34.8% in the past two years. The top five in terms of the total amount of three-year medication were Enron, Cleopatra, , Switzerland, most of the drugs in the three years of sales growth rates fluctuate; DDDs 3-year ranking unchanged, the top three are capable, 100 Purdy, Rui Dai. Conclusion The enteral nutrition has a larger increase in the use of drugs, but the proportion in the use of nutritional drugs has decreased. If the patient’s intestine also retains a certain function, it should be as far as possible the application of enteral nutrition drugs.